1. ALK INHIBITORS SAFETY PROFILE IN PEDIATRIC PATIENTS TREATED FOR AN ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA: REAL LIFE EXPERIENCE AMONG A FRENCH COHORT. (October 2022) Authors: d'Hautefeuille, C.; Abbou, S.; El-Gourari-Miaz, L.; Lambilliotte, A.; Renard, C.; Landman-Parker, J.; Gourdon, S.; Metayer, L.; Leblanc, T.; Pacquement, H.; Rabian, F.; Verschuur, A.; Brasme, J.; Millot, F.; Pagnier, A.; Buchbinder, N.; Rorhlich, P.; Minard-Colin, V.; Brugières, L.; Ducassou, S. Journal: Leukemia research Issue: Volume 121(2022)Supplement Page Start: S68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗